Neurodegeneration and neuroprotection in Parkinson disease
Open accessThe DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Frequency Dependence of Signal Power and Spatial Reach of the Local Field Potential
Leski, S., Lindén, H., Tetzlaff, T., Pettersen, K. H., & Einevoll, G. T. (2013) · PubMed · doi:10.18154/rwth-conv-084442 · Cited by 3,639
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
Burns, R. S., Chiueh, C. C., Markey, S. P., Ebert, M. H., Jacobowitz, D. M., & Kopin, I. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4546 · Cited by 2,149
Aggresomes: A Cellular Response to Misfolded Proteins
Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Self-citationSynuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,641
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,480
Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,433
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Chronic parkinsonism secondary to intravenous injection of meperidine analogues
Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,376
Javitch, J. A., D'Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,263
Kordower, J. H., Emborg, M. E., Bloch, J., Ma, S. Y., Chu, Y., Leventhal, L., McBride, J., Chen, E.-Y., Palfi, S., Roitberg, B. Z., et al. (2000) · Science · doi:10.1126/science.290.5492.767 · Cited by 1,251
Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280305 · Cited by 1,221
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · cited 2×
“The authors of this initial report suggested that the toxic compound could have been MPTP.”
BackgroundKinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones
GRAHAM, D. G. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13535-9 · Cited by 1,126
Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984 · cited 1×
“They were randomized into four equal arms and assigned 300 mg/day, 600 mg/day, 1,200 mg/day or placebo and followed up to 16 months.(150) There was a positive trend (p 0.”
BackgroundZhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
Description of Parkinson's Disease as a Clinical Syndrome
FAHN, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07458.x · Cited by 977
Self-citationFunctional recovery in parkinsonian monkeys treated with GDNF
Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., et al. (1996) · Nature · doi:10.1038/380252a0 · Cited by 955
Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease
The Parkinson Study Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212004 · Cited by 917
Parkinson Disease in Twins: An Etiologic Study
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 867
Cabin, D. E., Shimazu, K., Murphy, D., Cole, N. B., Gottschalk, W., McIlwain, K. L., Orrison, B., Chen, A., Ellis, C. E., Paylor, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08797.2002 · Cited by 865
Murphy, D. D., Rueter, S. M., Trojanowski, J. Q., & Lee, V. M.-Y. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03214.2000 · Cited by 836
de Rijk, M. C., Tzourio, C., Breteler, M. M., Dartigues, J. F., Amaducci, L., Lopez-Pousa, S., Manubens-Bertran, J. M., Alperovitch, A., & Rocca, W. A. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.1.10 · Cited by 833
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
Nutt, J. G., Burchiel, K. J., Comella, C. L., Jankovic, J., Lang, A. E., Laws, E. R., Lozano, A. M., Penn, R. D., Simpson, R. K., Stacy, M., et al. (2003) · Neurology · doi:10.1212/wnl.60.1.69 · Cited by 824
A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
Hernán, M. A., Takkouche, B., Caamaño‐Isorna, F., & Gestal‐Otero, J. J. (2002) · Annals of Neurology · doi:10.1002/ana.10277 · Cited by 818 · cited 12×
“Moreover, the pattern of neuronal loss in the SN in patients with PD and in the normal aging population differs, 18 again indicating that accelerated aging alone is not responsible for causing PD.”
BackgroundInfluentialDu, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
Markey, S. P., Johannessen, J. N., Chiueh, C. C., Burns, R. S., & Herkenham, M. A. (1984) · Nature · doi:10.1038/311464a0 · Cited by 786
Clayton, D. F., & George, J. M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01213-7 · Cited by 779
Volles, M. J., Lee, S.-J., Rochet, J.-C., Shtilerman, M. D., Ding, T. T., Kessler, J. C., & Lansbury, P. T. (2001) · Biochemistry · doi:10.1021/bi0102398 · Cited by 682
Schapira, A. H. V., Mann, V. M., Cooper, J. M., Dexter, D., Daniel, S. E., Jenner, P., Clark, J. B., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05809.x · Cited by 673
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
Teismann, P., Tieu, K., Choi, D.-K., Wu, D.-C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837397100 · Cited by 660
Epidemiology of parkinson’s disease
Tanner, C. M., & Goldman, S. M. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70259-0 · Cited by 640
Systematic review of incidence studies of Parkinson's disease
Twelves, D., Perkins, K. S. M., & Counsell, C. (2003) · Movement Disorders · doi:10.1002/mds.10305 · Cited by 622
A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis
Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F., & Zigmond, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03090.2002 · Cited by 598
A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter
Liu, Y. (1992) · Cell · doi:10.1016/0092-8674(92)90425-c · Cited by 594
Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
Dauer, W., Kholodilov, N., Vila, M., Trillat, A.-C., Goodchild, R., Larsen, K. E., Staal, R., Tieu, K., Schmitz, Y., Yuan, C. A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172514599 · Cited by 581
Self-citationMatthews, R. T., Yang, L., Browne, S., Baik, M., & Beal, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8892 · Cited by 557
Freezing of gait in PD: Prospective assessment in the DATATOP cohort
Giladi, N., McDermott, M. P., Fahn, S., Przedborski, S., Jankovic, J., Stern, M., Tanner, C., & The Parkinson Study Group (2001) · Neurology · doi:10.1212/wnl.56.12.1712 · Cited by 545
Self-citationParkinson’s disease and parkinsonism in a longitudinal study: Two-fold higher incidence in men
Baldereschi, M., Di Carlo, A., Rocca, W. A., Vanni, P., Maggi, S., Perissinotto, E., Grigoletto, F., Amaducci, L., & Inzitari, D. (2000) · Neurology · doi:10.1212/wnl.55.9.1358 · Cited by 526
Davidson, C., Gow, A. J., Lee, T. H., & Ellinwood, E. H. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00054-6 · Cited by 521
Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions
Engelender, S., Kaminsky, Z., Guo, X., Sharp, A. H., Amaravi, R. K., Kleiderlein, J. J., Margolis, R. L., Troncoso, J. C., Lanahan, A. A., Worley, P. F., et al. (1999) · Nature Genetics · doi:10.1038/8820 · Cited by 489
Widner, H., Tetrud, J., Rehncrona, S., Snow, B., Brundin, P., Gustavii, B., Björklund, A., Lindvall, O., & Langston, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211263272203 · Cited by 488
Lewy bodies and parkinsonism in families with parkin mutations
Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Gwinn‐Hardy, K., Petrucelli, L., Hussey, J., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1132 · Cited by 485
(2001) · doi:10.1523/jneurosci.21-24-09549.2001 · Cited by 476
(2002) · doi:10.1016/s0896-6273(02)01125-x · Cited by 473
Seibyl, J. P., Marchek, K. L., Quinlan, D., Sheff, K., Zoghbi, S., Zea‐Ponce, Y., Baldwin, R. M., Fussell, B., Smith, E. O., Charney, D. S., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380407 · Cited by 467
LEE, F. J. S., LIU, F., PRISTUPA, Z. B., & NIZNIK, H. B. (2001) · The FASEB Journal · doi:10.1096/fj.00-0334com · Cited by 455
Cubells, J., Rayport, S., Rajendran, G., & Sulzer, D. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-04-02260.1994 · Cited by 448
Self-citationInduction of α-Synuclein Aggregation by Intracellular Nitrative Insult
Paxinou, E., Chen, Q., Weisse, M., Giasson, B. I., Norris, E. H., Rueter, S. M., Trojanowski, J. Q., Lee, V. M.-Y., & Ischiropoulos, H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08053.2001 · Cited by 440
Sulzer, D., Bogulavsky, J., Larsen, K. E., Behr, G., Karatekin, E., Kleinman, M. H., Turro, N., Krantz, D., Edwards, R. H., Greene, L. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.11869 · Cited by 407
Self-citationParkinson's Disease in a Chemist Working with 1-Methyl-4-Phenyl-L,2,5,6-Tetrahydropyridine
(1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090511 · Cited by 406
Sulzer, D., & Rayport, S. (1990) · Neuron · doi:10.1016/0896-6273(90)90339-h · Cited by 389 · cited 1×
“micromolar concentrations and is a comparatively oxidizing environment.(87) The resulting oxidized compound, DA-quinone, has been found to react with the DA uptake transporter,(91) and as above, synuclein,(41) and is”
BackgroundSelf-citationMayeux, R., Marder, K., Cote, L. J., Denaro, J., Hemenegildo, N., Mejia, H., Tang, M.-X., Lantigua, R., Wilder, D., Gurland, B., et al. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117721 · Cited by 387
Staropoli, J. F., McDermott, C., Martinat, C., Schulman, B., Demireva, E., & Abeliovich, A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00084-9 · Cited by 381
An [18F]dopa–PET and clinical study of the rate of progression in Parkinson’s disease
Morrish, P. K., Sawle, G. V., & Brooks, D. J. (1996) · Brain · doi:10.1093/brain/119.2.585 · Cited by 366
Parkin Suppresses Dopaminergic Neuron-Selective Neurotoxicity Induced by Pael-R in Drosophila
Yang, Y., Nishimura, I., Imai, Y., Takahashi, R., & Lu, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00143-0 · Cited by 364
Brain iron pathways and their relevance to Parkinson's disease
Berg, D., Gerlach, M., Youdim, M. B. H., Double, K. L., Zecca, L., Riederer, P., & Becker, G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00608.x · Cited by 362
Gainetdinov, R. R., Fumagalli, F., Jones, S. R., & Caron, M. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031322.x · Cited by 353
Effect of Mutant α-Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell Line
Lotharius, J., Barg, S., Wiekop, P., Lundberg, C., Raymon, H. K., & Brundin, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205518200 · Cited by 352
Wilms, H., Rosenstiel, P., Sievers, J., Deuschl, G., Zecca, L., & Lucius, R. (2003) · The FASEB Journal · doi:10.1096/fj.02-0314fje · Cited by 337
Larsen, K. E., Fon, E. A., Hastings, T. G., Edwards, R. H., & Sulzer, D. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08951.2002 · Cited by 335
Self-citationDifferential expression of two vesicular monoamine transporters
Peter, D., Liu, Y., Sternini, C., de Giorgio, R., Brecha, N., & Edwards, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-09-06179.1995 · Cited by 333
Steiner, J. P., Hamilton, G. S., Ross, D. T., Valentine, H. L., Guo, H., Connolly, M. A., Liang, S., Ramsey, C., Li, J.-H. J., Huang, W., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2019 · Cited by 327
Shults, C. W., Haas, R. H., Passov, D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410420221 · Cited by 326
The role of glial cells in Parkinsonʼs disease
Vila, M., Jackson-Lewis, V., Guégan, C., Chu Wu, D., Teismann, P., Choi, D.-K., Tieu, K., & Przedborski, S. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00009 · Cited by 326
Presynaptic Recording of Quanta from Midbrain Dopamine Neurons and Modulation of the Quantal Size
Pothos, E. N., Davila, V., & Sulzer, D. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-11-04106.1998 · Cited by 320
Self-citationUptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP
Javitch, J. A., & Snyder, S. H. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90740-4 · Cited by 317
DJ-1 Positively Regulates the Androgen Receptor by Impairing the Binding of PIASxα to the Receptor
Takahashi, K., Taira, T., Niki, T., Seino, C., Iguchi-Ariga, S. M. M., & Ariga, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101730200 · Cited by 314
Biomedical and clinical aspects of coenzyme Q
Littarru, G. P. (1993) · The Clinical Investigator · doi:10.1007/bf00184478 · Cited by 310
The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation
Lotharius, J., & O'Malley, K. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005385200 · Cited by 306
Striatal dopamine deficiency in parkinson's disease: Role of aging
Scherman, D., Desnos, C., Darchen, F., Pollak, P., Javoy‐Agid, F., & Agid, Y. (1989) · Annals of Neurology · doi:10.1002/ana.410260409 · Cited by 286
Intraneuronal dopamine-quinone synthesis: a review
Sulzer, D., & Zecca, L. (1999) · Neurotoxicity Research · doi:10.1007/bf03033289 · Cited by 284
Self-citationExcitotoxicity and nitric oxide in parkinson's disease pathogenesis
Beal, M. F. (1998) · Annals of Neurology · doi:10.1002/ana.410440716 · Cited by 283
Grondin, R., Zhang, Z., Yi, A., Cass, W. A., Maswood, N., Andersen, A. H., Elsberry, D. D., Klein, M. C., Gerhardt, G. A., & Gash, D. M. (2002) · Brain · doi:10.1093/brain/awf234 · Cited by 283
Kish, S. J., Shannak, K., Rajput, A., Deck, J. H. N., & Hornykiewicz, O. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09766.x · Cited by 272
Ramsay, R. R., Salach, J. I., & Singer, T. P. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80483-1 · Cited by 272
Chronic Manganese Intoxication
Huang, C.-C., Chu, N.-S., Lu, C.-S., Wang, J.-D., Tsai, J.-L., Tzeng, J.-L., Wolters, E. C., & Calne, D. B. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460090018 · Cited by 267
Fumagalli, F., Gainetdinov, R. R., Valenzano, K. J., & Caron, M. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04861.1998 · Cited by 266
Shoulson, I., Oakes, D., Fahn, S., Lang, A., Langston, J. W., LeWitt, P., Olanow, C. W., Penney, J. B., Tanner, C., Kieburtz, K., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10191 · Cited by 258
Self-citationIV. MPTP, MPP+ and mitochondrial function
Nicklas, W. J., Youngster, S. K., Kindt, M. V., & Heikkila, R. E. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90299-2 · Cited by 257
Mitsumoto, A., Nakagawa, Y., Takeuchi, A., Okawa, K., Iwamatsu, A., & Takanezawa, Y. (2001) · Free Radical Research · doi:10.1080/10715760100300831 · Cited by 257
Louis, E. D., Mayer, S. A., & Rowland, L. P. (2001) · Cited by 243
Autophagy in neurons: a review.
Larsen, K. E., & Sulzer, D. L. (2002) · PubMed · doi:10.14670/hh-17.897 · Cited by 241
Self-citationFumagalli, F., Gainetdinov, R. R., Wang, Y.-M., Valenzano, K. J., Miller, G. W., & Caron, M. G. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02424.1999 · Cited by 241
Bioenergetic approaches for neuroprotection in Parkinson's disease
Beal, M. F. (2003) · Annals of Neurology · doi:10.1002/ana.10479 · Cited by 236
Chronic Manganese Intoxication
Cook, D. G., Fahn, S., & Brait, K. A. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490310061010 · Cited by 229
Self-citationRiluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study
Benazzouz, A., Boraud, T., Dubédat, P., Boireau, A., Stutzmann, J.-M., & Gross, C. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00362-o · Cited by 223
Vingerhoets, F. J. G., Snow, B. J., Lee, C. S., Schulzer, M., Mak, E., & Calne, D. B. (1994) · Annals of Neurology · doi:10.1002/ana.410360512 · Cited by 218
Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease
Foroud, T., Uniacke, S. K., Liu, L., Pankratz, N., Rudolph, A., Halter, C., Shults, C., Marder, K., Conneally, P. M., Nichols, W. C., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000049470.00180.07 · Cited by 214
Synaptic Vesicle Transporter Expression Regulates Vesicle Phenotype and Quantal Size
Pothos, E. N., Larsen, K. E., Krantz, D. E., Liu, Y.-J., Haycock, J. W., Setlik, W., Gershon, M. D., Edwards, R. H., & Sulzer, D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-19-07297.2000 · Cited by 211
Self-citationGiovanni, A., Liang, L. P., Hastings, T. G., & Zigmond, M. J. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041819.x · Cited by 202
Lysosomes, a meeting point of proteins, chaperones, and proteases
Cuervo, A. M., & Dice, J. F. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050185 · Cited by 201
Uversky, V. N., Li, J., Bower, K., & Fink, A. L. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00067-0 · Cited by 200
Modification of Chronic Manganese Poisoning: Treatment with L-Dopa or 5-OH Tryptophane
Mena, I., Court, J., Fuenzalida, S., Papavasiliou, P. S., & Cotzias, G. C. (1970) · New England Journal of Medicine · doi:10.1056/nejm197001012820102 · Cited by 196
Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter
Whitehead, R. E., Ferrer, J. V., Javitch, J. A., & Justice, J. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00125.x · Cited by 194
Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., Kimura, J., & Shimohama, S. (1998) · Annals of Neurology · doi:10.1002/ana.410440117 · Cited by 193
Iacopino, A., Christakos, S., German, D., Sonsalla, P. K., & Altar, C. A. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90033-8 · Cited by 191
MPTP: a review of its mechanisms of neurotoxicity
Przedborski, S., & Vila, M. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00019-6 · Cited by 191
Przedborski, S., Chen, Q., Vila, M., Giasson, B. I., Djaldatti, R., Vukosavic, S., Souza, J. M., Jackson‐Lewis, V., Lee, V. M. ‐., & Ischiropoulos, H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00174.x · Cited by 190
Certain Metals Trigger Fibrillation of Methionine-oxidized α-Synuclein
Yamin, G., Glaser, C. B., Uversky, V. N., & Fink, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303302200 · Cited by 178
Increased MPTP Neurotoxicity in Vesicular Monoamine Transporter 2 Heterozygote Knockout Mice
Gainetdinov, R. R., Fumagalli, F., Wang, Y., Jones, S. R., Levey, A. I., Miller, G. W., & Caron, M. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051973.x · Cited by 178
Characterization of Cytoplasmic α-Synuclein Aggregates
Lee, H.-J., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208192200 · Cited by 173
Nitration and Inactivation of Tyrosine Hydroxylase by Peroxynitrite
Blanchard-Fillion, B., Souza, J. M., Friel, T., Jiang, G. C. T., Vrana, K., Sharov, V., Barrón, L., Schöneich, C., Quijano, C., Alvarez, B., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105564200 · Cited by 172
Selegiline as initial treatment in de novo parkinsonian patients
Myllylä, V. V., Sotaniemi, K. A., Vuorinen, J. A., & Heinonen, E. H. (1992) · Neurology · doi:10.1212/wnl.42.2.339 · Cited by 171
Molecular features of human ubiquitin-like SUMO genes and their encoded proteins
Su, H.-L., & Li, S. S.-L. (2002) · Gene · doi:10.1016/s0378-1119(02)00843-0 · Cited by 158
Preservation of midbrain catecholaminergic neurons in very old human subjects
Kubis, N., Faucheux, B. A., Ransmayr, G., Damier, P., Duyckaerts, C., Henin, D., Forette, B., Le Charpentier, Y., Hauw, J.-J., Agid, Y., et al. (2000) · Brain · doi:10.1093/brain/123.2.366 · Cited by 157
Burke, R. E., Antonelli, M., & Sulzer, D. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71020517.x · Cited by 156
Self-citationSelegiline delays the onset of disability in de novo parkinsonian patients
Pålhagen, S., Heinonen, E. H., Hägglund, J., Kaugesaar, T., Kontants, H., Mäki-Ikola, O., Palm, R., Turunen, J., & *Swedish Parkinson Study Group (1998) · Neurology · doi:10.1212/wnl.51.2.520 · Cited by 149
Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity
Przedborski, S., Jackson‐Lewis, V., Muthane, U., Jiang, H., Ferreira, M., Naini, A. B., & Fahn, S. (1993) · Annals of Neurology · doi:10.1002/ana.410340515 · Cited by 149
Self-citationParkinson Disease With Old-Age Onset: A Comparative Study With Subjects With Middle-Age Onset
Diederich, N. J., Moore, C. G., Leurgans, S. E., Chmura, T. A., & Goetz, C. G. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.529 · Cited by 147
Parkin Accumulation in Aggresomes Due to Proteasome Impairment
Junn, E., Lee, S. S., Suhr, U. T., & Mouradian, M. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203159200 · Cited by 145
Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET.
Eidelberg, D., Moeller, J. R., Ishikawa, T., DHAWAN, V. M., Spetsieris, P. G., Chaly, T., Robeson, W., Dahl, J., & Margouleff, D. (1995) · PubMed · Cited by 136
Epidemiology of Parkinson’s Disease
Tanner, C. M. (1992) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30212-3 · Cited by 126
Colmenares, M. (2002) · Journal of Biological Chemistry · Cited by 122
Bower, J. H., Maraganore, D. M., McDonnell, S. K., & Rocca, W. A. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<819::aid-mds1009>3.0.co;2-p · Cited by 120
Ribeiro, C. S., Carneiro, K., Ross, C. A., Menezes, J. R. L., & Engelender, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201115200 · Cited by 119
The neuromelanin of human substantia nigra and its interaction with metals
Zecca, L., Tampellini, D., Gatti, A., Crippa, P. R., Eisner, M., Sulzer, D., Ito, S., Fariello, R. G., & Gallorini, M. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200055 · Cited by 110
Self-citationCookson, M. (2003) · Neuron · doi:10.1016/s0896-6273(02)01166-2 · Cited by 104
Pothos, E. N., Mosharov, E., Liu, K., Setlik, W., Haburcak, M., Baldini, G., Gershon, M. D., Tamir, H., & Sulzer, D. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.018630 · Cited by 102
Self-citationGuo, X., Dawson, V. L., & Dawson, T. M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01542.x · Cited by 95
Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat
Barnéoud, P., Mazadier, M., Miquet, J.-M., Parmentier, S., Dubédat, P., Doble, A., & Boireau, A. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00249-7 · Cited by 88
A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease
Jankovic, J. J., & Hunter, C. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00040-2 · Cited by 83
Matthews, R. T., Yang, L., & Beal, M. F. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6406 · Cited by 83
Selegiline can mediate neuronal rescue rather than neuronal protection
Tatton, W. G. (1993) · Movement Disorders · doi:10.1002/mds.870080506 · Cited by 77
Booij, J., Bergmans, P., Winogrodzka, A., Speelman, J. D., & Wolters, E. C. (2001) · Synapse · doi:10.1002/1098-2396(200102)39:2<101::aid-syn1>3.0.co;2-1 · Cited by 71
Staal, R. G. W., Hogan, K. A., Liang, C., German, D. C., & Sonsalla, P. K. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39239-0 · Cited by 65
PIPERIDINE DERIVATIVES. PART III. 4-ARYLPIPERIDINES1
Ziering, A., BERGER, L., HEINEMAN, S. D., et al. (1947) · The Journal of Organic Chemistry · doi:10.1021/jo01170a022 · Cited by 65
Harper, S., Bilsland, J., Young, L., Bristow, L. J., Boyce, S., Mason, G. S., Rigby, M., Hewson, L., Smith, D. S., O’Donnell, R., et al. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00221-8 · Cited by 64
Obinu, M. C., Reibaud, M., Blanchard, V., Moussaoui, S. M., & Impérato, A. (2002) · Movement Disorders · doi:10.1002/mds.1272 · Cited by 64
Gluck, M., Ehrhart, J., Jayatilleke, E., & Zeevalk, G. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00938.x · Cited by 61
Apoptosis as a general cell death pathway in neurodegenerative diseases
Offen, D., Elkon, H., & Melamed, E. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6284-2_13 · Cited by 60
Liss, B., Neu, A., & Roeper, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08839.1999 · Cited by 60
Systemic Administration of the Immunophilin Ligand GPI 1046 in MPTP-Treated Monkeys
Emborg, M. E., Shin, P., Roitberg, B. Z., Sramek, J. G., Chu, Y., Stebbins, G. T., Hamilton, J. S., Suzdak, P. D., Steiner, J. P., & Kordower, J. H. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7592 · Cited by 59
CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease
Waldmeier, P. C., Spooren, W. P. J. M., & Hengerer, B. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000300 · Cited by 55
Reconciling Humane Concerns and Laboratory Animal Research
Wright, J. M., Wall, R. A., Perry, T. L., & Paty, D. W. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402023100520 · Cited by 45
The Cell Biology of α Synuclein
Cole, N. B., & Murphy, D. D. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:1:2:95 · Cited by 38
The Case of the Frozen Addicts
Palfreman, J., & Langston, J. W. (1995) · Cited by 33
Failure of GPI compounds to display neurotrophic activity in vitro and in vivo
Bocquet, A., Lorent, G., Fuks, B., Grimée, R., Talaga, P. E., Daliers, J., & Klitgaard, H. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00850-0 · Cited by 31
Sulfonylurea-sensitive potassium current evoked by sodium-loading in rat midbrain dopamine neurons
Seutin, V., Shen, K., North, R. A., & Johnson, S. W. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00489-0 · Cited by 28
GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum
Tanaka, K.-I., Yoshioka, M., Miyazaki, I., Fujita, N., & Ogawa, N. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02547-2 · Cited by 27
The Immunophilin Ligand GPI-1046 Does Not Have Neuroregenerative Effects in MPTP-Treated Monkeys
Eberling, J. L., Pivirotto, P., Bringas, J., Steiner, J. P., Kordower, J. H., Chu, Y., Emborg, M. E., & Bankiewicz, K. S. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8023 · Cited by 19
Correlation of Parkinson's disease severity and duration with123I-FP-CIT SPECT striatal uptake
Benamer, H. T. S., Patterson, J., Wyper, D. J., Hadley, D. M., Macphee, G. J. A., & Grosset, D. G. (2000) · Movement Disorders · doi:10.1002/1531-8257(200007)15:4<692::aid-mds1014>3.0.co;2-v
Cited by
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
Oxidative Stress and Antioxidants in Neurodegenerative Disorders
Olufunmilayo, E. O., Gerke-Duncan, M. B., & Holsinger, R. M. D. (2023) · Antioxidants · doi:10.3390/antiox12020517 · Cited by 670
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
Sulzer, D. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.009 · Cited by 587
Self-citationThe Synaptic Function of α-Synuclein
Burré, J. (2015) · Journal of Parkinson's Disease · doi:10.3233/jpd-150642 · Cited by 573
Metadata
- Authors
- Fahn, S., & Sulzer, D.
- Venue
- NeuroRX
- Published
- 2004-01
- Volume
- 1
- Issue
- 1
- Pages
- 139-154
- ISSN
- 1545-5343 (ISSN-L)
- OpenAlex
- W1982666490
- Cited by
- 257
- References
- 154
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.